• The Caris Life Sciences laboratory has achieved the highest level of quality certification.
• Tumour profiling at the Caris lab is subject to stringent quality controls and conducted by a group of specialised scientists.
• The Caris lab contains the latest tumour profiling technologies to enable the most comprehensive, up to date profile possible.
Exclusive partner of Caris Molecular Intelligence in Australia and New Zealand. 
Videos
Why is tumour profiling different?
• Tumour profiling provides unique information to enable personalised cancer treatment.
• Caris Life Sciences uses a multi-technology platform to generate the most comprehensive tumour profile available.
• Fast reliable results identify new treatment options for patients who have not responded to the standard of care therapy.
Caris Centers of Excellence for Precision Medicine Network
Caris Centres of Excellence lead the development of scientific evidence for the molecular profiling of cancer tumours, to advance precision medicine.
Navzad’s Cancer: Caris Cancer Profiling | SBS Insights – Cancer Breakthroughs
• Molecular profiling helps doctors understand why tissues change to be cancerous, and which genetic mutations are driving cancer growth.
• Anti-cancer drugs can then be matched to genetic mutations in the tumour.
• Breakthroughs in molecular profiling of tumours are enhancing cancer treatment.
Kidney Cancer: Doug’s story
• Doug was given one year to live when first diagnosed with cancer
• He had molecular profiling of his cancer’s DNA, RNA and proteins performed with Caris
• Years later, he’s “doing well”, watching his grandchildren grow up.
Colon Cancer: Melanie’s story
• Melanie experienced cancer, recurring at different sites for seven years.
• Caris tumour profiling of her colorectal cancer revealed it had markers common to breast and kidney cancer.
• She’s doing well, after receiving targeted therapies, usually used to treat completely different types of cancer.
Breast Cancer: Sandy’s story
• Sandy’s cancer, first diagnosed in 1992, recurred in 2002 in her liver, bone and lungs.
• Standard therapies were no longer working, so she tried tumour profiling, to identify personalised medicine.
• Anti-cancer drugs identified through molecular profiling, have managed her cancer and given her the time to experience her children’s graduations, marriages and birth of grandchildren.
Print 
PDFCreated: December 15, 2016 - Modified: March 27, 2017